Phibro Animal Health CorporationPAHCNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR-1.0%
5Y CAGR-9.7%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-1.0%/yr
vs -22.3%/yr prior
5Y CAGR
-9.7%/yr
Recent acceleration
Acceleration
+21.3pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthCompressed
PeriodValueYoY Change
20250.80+17.7%
20240.68+19.5%
20230.57-31.0%
20220.82-41.4%
20211.40+5.6%
20201.33-13.9%
20191.54-31.6%
20182.26+17.9%
20171.91+96.2%
20160.98-